×

收藏-健康网会员访问记录

网页标题:
×

注册健康网用户

用 户 名:
联 系 人:
性  别:
密  码:
重复密码:
电子邮箱:
邮箱验证码:
固定电话:
传  真:
手  机:
单位名称:
通信地址:
首选栏目:
×

找回密码

  • 1.选择找回方式
  • 2.确认验证信息
  • 3.修改密码
  • 4.修改成功
  • 找回方式:
  • 用 户 名:
  • 手机号码:

 您现在位置:健康网-医药产业 >> 研究报告 >> English reports >> English reports >> 浏览医药行业研究报告

Hemostatic Drugs and Hemocoagulase Report

作者:wangchun   来源:本站原创    点击数:0    更新时间:2007-10-11 16:22:26

[关键字]: Hemostatic Drugs,Hemocoagulase

健康网讯:

Market Research Report on Hemostatic Drugs and Hemocoagulase (2007 edition)

Publisher: Orient Health Electronic Commercial(Beijing)co.,Ltd
Format:  Hardcopy and Adobe PDF
Price:  US$1,960
Contact: Mr. Bian chenghua   Ms. Wu huifang
Tel.: 86-10-68012929-2116/2101             Fax:  86-10-68052505
E-mail: bianch@healthoo.com   wuhf@healthoo.com

The table of contents
1 Categories and action mechanisms of Hemostatic Drugs
  1.1 Categories and action mechanisms
  1.2 Hemocoagulase (Batroxobin) basic infromation and applications
    1.2.1 basic infromation
    1.2.2 R&D process
    1.2.3 characteristic of molecule structure
    1.2.4 characteristic of enzymology
    1.2.5 pharmacologic action
    1.2.6 clinical applications
  1.3 Thrombin basic infromation and applications
  1.4 Aprotinin basic infromation and applications
  1.5 Tranexamic Acid basic infromation and applications
2 Market status of Hemostatic Drugs
  2.1 Market sizes and growth trend from 2002 to 2006
  2.2 Sales values of different breeds from 2002 to 2006
  2.3 Market shares of different brands from 2002 to 2006
3 Market analysis of key breeds in 2006
  3.1 Market shares of different breeds
  3.2 Market shares of different brands
  3.3 Key breeds analysis
    3.3.1 Hemocoagulase
    3.3.2 Tranexamic Acid
    3.3.3 Aprotinin
    3.3.4 prothrombin complex
    3.3.5 Thrombin
    3.3.6 recombination coagulation factor VIIa
    3.3.7 human fibrinogen
    3.3.8 Carbazochrome
    3.3.9 Aminomethylbenzoic Acid
    3.3.10 Lyophilized Human Coagulation Factor VIII
    3.3.11 ethylenediamine diaceturate
    3.3.12 other
  3.4 Retail prices of key breeds
4 R&D information of new drugs
5. Information of researhing and development in China
  5.1 Domestic and imported drugs on the market
  5.2 Status of application and approval
6 Our suggestion
Appendix 1: Infromation of application and approval for hemostatic drugs
Appendix 2: The hemostatic drugs listed in Drug Catalogue of National Basic Medical Insurance

Hemostatic Drugs and Hemocoagulase Report
注册后,我们会为你提供报告样本并为您提供更全面的咨询服务
您的姓名  称谓: 先生女士
手机号码 
验证号码 
电子邮件 
单位名称 

服务热线

  • 联系项目:86-10-68012929-2103
  • 订购报告:86-10-68012929-2121
  • 邮件订购:leigy@healthoo.com